Welcome to our dedicated page for Body And Mind news (Ticker: BMMJ), a resource for investors and traders seeking the latest updates and insights on Body And Mind stock.
Body and Mind Inc. ("BaM") (BMMJ) generates frequent corporate news as an operations-focused cannabis company active in regulated U.S. retail markets. Its news releases provide insight into how the company manages its retail cannabis dispensaries, development projects, financing arrangements, and regulatory obligations.
BaM’s recent announcements highlight several key themes. The company has reported agreements to divest dispensary assets and subsidiaries in Nevada, California, Illinois, and New Jersey through membership interest purchase agreements and asset purchase agreements. These items of news often include details on cash consideration, escrow arrangements, potential earnouts, and state-level regulatory approvals required for closing.
Another category of news covers BaM’s financial reporting and regulatory status. The company has disclosed delays in filing annual and interim financial statements, the need to restate certain quarterly financial reports due to accounting treatment of a variable interest entity and management fee income, and the issuance of a cease trade order by the British Columbia Securities Commission. Updates on audit progress, planned amended filings, and management’s efforts to address these matters are central topics in these releases.
BaM also issues updates on store openings, such as the grand opening of a Lynwood, Illinois dispensary, and on subsequent agreements to sell those locations to other operators. In addition, the company has reported amendments to its credit facility with Bengal Catalyst Fund, including changes to borrowing capacity, interest rates, and forbearance terms.
Investors and observers following BMMJ news can use this page to review BaM’s disclosures on retail operations, asset sales, financial reporting developments, and regulatory actions. Regularly reviewing these updates can help readers understand how the company is adjusting its retail footprint, managing capital, and responding to the challenges it identifies in the cannabis industry.
Summary not available.
Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) has announced significant progress in its operations, including the upcoming launch of a Body and Mind-branded dispensary in Markham, Illinois. The company has received a temporary occupancy permit and plans to open within weeks. Concurrently, Body and Mind is divesting its dispensary in Michigan through a stock purchase agreement, which involves a third party assuming the long-term lease and inventory. The company, focused on enhancing its market share, recognizes these endeavors as crucial for future growth. Its broader strategy includes operating dispensaries in Illinois and New Jersey, aiming to drive profitability and enhance shareholder value.
Body and Mind Inc. (OTCQB: BMMJ) reported $7.7 million in revenue for Q2 FY 2023, slightly down from $7.8 million in Q1 FY 2023. The company incurred a net loss of $2.7 million, improving from $3.0 million previously. Gross profit rose to $2.26 million, up from $1.6 million. The company advanced its operations in Illinois and New Jersey and is set to open its first Illinois dispensary in April 2023. Significant wholesale price improvements in Nevada and Ohio contributed positively to financial results.
Body and Mind Inc. (OTCQB: BMMJ) has provided a corporate update regarding the construction of two new dispensaries in Illinois. The Markham location is expected to open by late April, strategically positioned in a high-traffic area with over 400,000 vehicles passing daily. The second dispensary in Southern Chicago has received community approval and is in the process of obtaining building permits. In 2022, Illinois cannabis sales reached $1.55 billion with only 113 dispensaries serving nearly 13 million people. Body and Mind is poised to enhance its presence in a largely underserved market.
Body and Mind Inc. (CNSX: BAMM; OTCQB: BMMJ) announced the appointment of Josh Rosen to its board of directors, enhancing its leadership as it expands into key markets like Illinois and New Jersey. Rosen, managing partner at Bengal Capital, previously led 4Front Ventures Corp., growing its operational focus and market presence. CEO Michael Mills expressed confidence in Rosen's expertise to drive value in the evolving cannabis sector. The company also acknowledged the contributions of Dong Shim, who remains as CFO, ensuring continuous leadership during this transition.
Body and Mind Inc. (OTCQB: BMMJ) reported Q1 FY 2023 revenues of $7.8 million, a slight increase of 3.4% from $7.6 million in Q1 FY 2022. However, the company faced a significant net loss of $3.0 million, compared to a $0.7 million loss in the previous year. Adjusted EBITDA reflected a loss of $1.6 million, worsening from $0.8 million in Q1 FY 2022. The company recently closed a $3 million convertible debt financing and made progress in expanding its operations in Illinois and New Jersey.
Body and Mind Inc. (CSE: BAMM, OTCQB: BMMJ) reported an annual revenue of $31.6 million for FY 2022, marking a 17.6% increase from $26.9 million in FY 2021. However, the company faced a net loss of $28.2 million, significantly higher than the previous year's loss of $2.0 million, primarily due to asset impairments totaling $20.5 million. Adjusted EBITDA for FY 2022 was a loss of $1.4 million, compared to a profit of $3.9 million in FY 2021. The company aims to expand its operations in Illinois and New Jersey while enhancing financial reporting.
Body and Mind Inc. (CSE: BAMM.US, OTCQB: BMMJ) announced a delay in filing its 2022 Annual Financial Filings for the year ending July 31, 2022. The audit process is nearly complete, pending final approval from an external consultant, updates on tax provisions, and internal quality control sign-off. The company is committed to transparency and will provide updates in accordance with National Policy 12-203. BaM operates in multiple states including Ohio, Arkansas, Michigan, and California, with plans to expand into Illinois and New Jersey.
Body and Mind Inc. (CSE: BAMM, OTCQB: BMMJ) has successfully closed a convertible debenture financing raising US$3.0 million led by Bengal Impact Partners. This funding will support the company's efforts to enter the New Jersey cannabis market through the acquisition of CraftedPlants NJ, Inc., which holds a retail location with local approval. Additionally, new board member Josh Rosen from Bengal Capital aims to enhance strategic operations. The financing includes provisions for warrants and registration rights, aligning interests for future growth.
Body and Mind Inc. (CSE: BAMM, OTCQB: BMMJ) has provided an update on the delay of its annual financial statements for the year ending July 31, 2022. The audit process is nearly complete, pending final approval from an external valuation consultant, tax provision updates, and quality control sign-off. The company is committed to transparency and will continue to update stakeholders according to National Policy 12-203. BaM operates active retail locations in several U.S. states and aims to expand its market share through customer satisfaction and operational efficiency.